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a b s t r a c t
The crosslinking agent genipin is increasingly invoked for the mechanical augmentation of collagen tis-
sues and implants, and has previously been demonstrated to arrest mechanical damage accumulation in
various tissues. This study established an in vitro dose–response baseline for the effects of genipin treat-
ment on tendon cells and their matrix, with a view to in vivo application to the repair of partial tendon
tears. Regression models based on a broad range of experimental data were used to delineate the range of
concentrations that are likely to achieve functionally effective crosslinking, and predict the corresponding
degree of cell loss and diminished metabolic activity that can be expected. On these data, it was con-
cluded that rapid mechanical augmentation of tissue properties can only be achieved by accepting some
degree of cytotoxicity, yet that post-treatment cell survival may be adequate to eventually repopulate
and stabilize the tissue. On this basis, development of delivery strategies and subsequent in vivo study
seems warranted.
 2014 The Authors. Published by Elsevier Ltd. Open access under CC BY license.
1. Introduction
Crosslinking has long been employed to augment the mechani-
cal properties of collagen-based implants for the repair or replace-
ment of musculoskeletal and cardiovascular tissues [1–3]. The
physiological environments of these systems can expose implants
to extreme physical demands that include high mechanical stres-
ses, high mechanical strains and/or highly repetitive loading. Such
loading regimes can overwhelm even native tissues, a fact that is
evidenced by high clinical rates of connective tissue disease and in-
jury [4].
Although tissue and biomaterial crosslinking strategies, tradi-
tionally using glutaraldehyde, have almost exclusively focused on
ex vivo chemical treatments of an implant prior to its application,
in vivo exogenous crosslinking has more recently been pursued (as
we recently reviewed in detail [5]). In this paradigm, the collagen
matrix of injured tissue is bolstered by judicious and targeted
application of low-toxicity crosslinkers. The idea here is to aug-
ment a tissue at the margins of a damaged region, arrest mechan-
ically driven tissue degeneration and possibly provide a foothold
for eventual recovery of tissue homeostasis. The use of ultraviolet
radiation (in combination with riboﬂavin as a photosensitizer) to
augment the biomechanical properties of connective tissues within
the eye [6] has by now become a common clinical treatment of
keratoconus [7], a disorder where local matrix weakness leads to
tissue bulging under ocular pressure. Proof of concept studies
using low toxicity crosslinkers in orthopedic applications are also
emerging [8,9].
Of the known low-toxic collagen crosslinking agents, one of the
best characterized is genipin (GEN), a naturally occurring organic
compound derived from the fruit of the gardenia plant (Gardenia
jasminoides). At acidic and neutral pH, GEN reacts with primary
amines of biopolymers and forms mono- up to tetramer crosslinks
[10]. With increasingly basic conditions, GEN further undergoes
ring-opening self-polymerization with increasing polymer length
prior to binding to primary amines [11]. With increasing polymer
length (4–88-mers), amine reactions with GEN slows, in turn
leading to less reduced enzyme digestibility and swelling by
GEN [12]. The feasibility and beneﬁt of employing GEN as an alter-
native to higher toxicity crosslinkers like glutaraldehyde has been
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demonstrated in a range of applications, including heart valves
[13], pericardial patches [14], conduits for nerve growth guidance
[15], scaffolds for tissue-engineered cartilage [16] and decellular-
ized tracheal transplantation [17], and as a more general applica-
tion to augment the strength and degradation properties of
collagen-based gels [15,18–21].
Our own efforts have demonstrated in an in vitro model that
application of GEN can arrest the progression of tendon lesions that
are characteristic of acute injury [9], and could potentially be of
beneﬁt in addressing this urgent and unmet clinical need (see
Ref. [22] for background on tendon tear prevalence and clinical
outcome). Tendon injuries are also widespread in equine athletes,
with much pathophysiological similarity to tendon injury in man
[23]. Using equine tendon, we demonstrated that immersion in a
high concentration GEN solution (20 mM for 3 days) could signiﬁ-
cantly recover post-injury tendon function, bringing it to a level
similar to that of uninjured controls. This functional recovery
was reﬂected in reduced tissue strains at a given mechanical stress,
increased tissue elasticity and the arrest of mechanical damage
accumulation during high-cycle dynamic loading. Although func-
tional efﬁcacy of these GEN treatments was clearly demonstrated,
the physiological implications (e.g. cell toxicity) of the treatment
were not investigated. More speciﬁcally, it was unclear what effect
GEN treatment has on resident cell populations, and whether GEN
concentrations at levels reported by others as non-cytotoxic
[16,24–28] could be sufﬁcient to elicit recovery of mechanical
integrity. This information is critical to guide further development
of GEN based clinical approaches to in situ tissue augmentation of
dense collagen-based connective tissues, including tendon. This
information is also necessary to guide the design and development
of delivery systems that can provide targeted (local) tissue aug-
mentation without unacceptable collateral damage to peripheral
tissues.
The ﬁrst aim of the present study was to investigate in vitro
dose-dependent tendon cell toxicity, exploring effects of both
treatment time and concentration. Previous studies have simi-
larly investigated a range of other cell types [16,24–28], with
variable results indicating that tissue speciﬁc investigation of rel-
evant cell phenotypes is warranted. The present series of studies
focus on tenocytes as a class of ﬁbroblastic cells derived from
dense collagen connective tissue that has not yet been investi-
gated. The second aim was to investigate the functional effects
of GEN treatment on tendon explants to establish dependency
of these effects on treatment concentration and duration. Ulti-
mately our goal was to determine whether a balance between
non-cytotoxicity and functional (biomechanical) efﬁcacy of GEN
dosing could be achieved, widening the potential range of viable
clinical applications for this increasingly used collagen crosslink-
ing agent.
2. Method
2.1. Study design
All studies were carried out on isolated cells or tissue explants
of the superﬁcial digital ﬂexor tendon (SDFT) from the front limbs
of freshly slaughtered horses collected from a local abattoir. All
experimental factors (treatment time and concentration) were
generally performed with tissue extracted from the same animal
and then replicated using tissue from additional animals. Samples
were subjected in a random manner to either sham-treatment
(incubated in genipin-free cell expansion medium) or in medium
supplemented with genipin at concentrations (cGEN) ranging from
0.02 to 20 mM. Incubation times of 24, 72 and 144 h were
investigated.
The experiments were conducted starting with a broad ap-
proach and progressively focusing on a more limited range of dos-
ages and their effects. First, cell-culture experiments were
performed to assess cytotoxicity in terms of relative cell viability
and metabolic activity. Using tissue explants, penetration of the
crosslinking agent was assessed, homogeneity of crosslink distri-
bution was quantiﬁed by inherent ﬂuorescence of GEN crosslinks
and the physical effects of the treatments were characterized as
changes in denaturation temperature. All these experiments were
performed over a wide range of concentrations and treatment
times, aiming to identify dosing regimes capable of altering the
physical properties of collagen with minimal cytotoxicity. In a sec-
ond phase, gene expression and cell motility were examined with-
in a reduced range of dosing regimes. Finally, tissue mechanics
were characterized for a targeted range of GEN dosing, to identify
minimal dosing thresholds able to achieve functionally relevant
changes in biomechanical properties.
2.2. Isolation of cells and tissue explants
Tissue explants were dissected from the core of the SDFT to a
standardized size of approximately 2  2  2 mm3 under sterile
conditions using previously described dissection methods [9], then
incubated in either GEN-supplemented or control medium. For iso-
lated cell-culture experiments, tendon cells were extracted by
digestion of explanted tissue using protease type XIV (Sigma–
Aldrich, St. Louis, MO) for 2 h at 37 C and collagenase B solution
(Roche, Burgess Hill, UK) for 16 h at 37 C. After the digestion pro-
cess, the mixture was ﬁltered and centrifuged. The cell pellet was
resuspended, seeded at a density of 104 cells cm2, then cultured
at 37 C and 5% CO2 in expansion medium (Dulbecco’s modiﬁed
Eagle’s medium, 10% fetal calf serum, 50 lg ml1 gentamicin and
1.5 lg ml1 fungizone, all from Life Technologies, Paisley, UK).
Cells used in experiments were either freshly digested or passaged
once at subconﬂuency.
2.3. Genipin crosslinking
A 20 mM stock solution of GEN (Challenge Bioproducts Co.,
Taiwan) was freshly prepared in expansion medium for each
experiment and then sterile ﬁltered (Millipore, Carrightwohill,
Cork, Ireland). The stock was then diluted to the required concentra-
tions. For explant cell viability and differential scanning calorimetry
(DSC), explants were incubated in culture dishes containing
GEN-supplemented medium at 37 C and 5% CO2; for tissue mechan-
ics, explants were incubated in Falcon tubes. Explants used for bio-
chemical analysis and crosslinking distribution were snap frozen
after treatment and stored at 80 C until later use.
2.4. Penetration and color changes
After GEN treatment, excess treatment solution was removed
by blotting the samples on clean cellulose tissue. Superﬁcial forma-
tion of blue pigmentation that qualitatively indicates GEN cross-
linking [29] was documented using a digital camera under
consistent illumination. The same samples were then embedded
in parafﬁn according to standard methods and cut into 6 lm sec-
tions (RM2265, Leica, Wetzlar, Germany). Inherent sample ﬂuores-
cence (excitation wavelength (kex): 510–560 nm; emission
wavelength (kem): 590 nm) was measured using a ﬂuorescence-
equipped upright microscope (Nikon Eclipse E600), since GEN
crosslinks have been shown to emit ﬂuorescence, with an expo-
nential correlation to mechanical properties (as measured by stor-
age modulus in collagen gels) [30].
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2.5. Cell-culture viability and metabolic activity
Cell viability and metabolic activity was compared to a sham/
positive control group (cells incubated in expansion medium only)
and to a negative control group (cells were killed with 70% meth-
anol for 1 h prior to the assay). For both tests the experiment
was replicated with cells from three tendons of different animals
(biological replication), with quadruple repeated measures per
experimental condition (technical replication). Cell viability was
measured using a viability/cytotoxicity assay (LIVE/DEAD Viabil-
ity/Cytotoxicity Kit, Molecular Probes, Life Technologies, Paisley,
UK) according to the manufacturer’s recommendations. Brieﬂy via-
bility was measured as relative ﬂuorescence (kex/kem: 485 nm/
530 nm) in a microplate reader (SpectraMAX Gemini XS, Molecular
Devices, Sunnyvale, CA) compared to controls. Similarly, cell met-
abolic activity was measured as ﬂuorescence (kex/kem: 560 nm/
590 nm) after 8 h of incubation in 10% alamarBlue (alamarBlue as-
say, Invitrogen), as previously described [31]. The control experi-
ment showed negligible inﬂuence of GEN light absorption
characteristics on these assays. Finally, intensities were converted
to cell viability (%) and metabolic activity (%):
FðkemÞGEN FðkemÞC
FðkemÞCþ;FðkemÞC ð1Þ
where F(kem) represents the average ﬂuorescence intensity of tech-
nical replications for each experimental condition at the wave-
length (kem) for each test, with C+ and C representing the
positive and negative controls, respectively.
2.6. Cell motility
Cell motility was determined using a standard scratch assay.
Brieﬂy, conﬂuent cell monolayers from three different animals
were treated in GEN or control medium for 3 days. The monolayers
were then scored with a sterile pipette microtip to leave a scratch
of approximately 0.5 mm width. The scratch widths were moni-
tored under an inverted microscope (Zeiss Observer Z1) over 9 h,
with digital images collected at 3 h intervals. The scratch width
was then measured (Image J software 1.44p, National Institute of
Health, USA). The cell migration speed (lm h1) was calculated
at 3, 6 and 9 h after the scratch, and the average cell velocity was
determined as the rate of scratch width closure divided by 2 to ac-
count for cell movement on each side of scratch.
2.7. Cell viability in explants
Equally sized tendon explants from ﬁve horses were weighed
(116 ± 12.3 mg) and GEN treated. After 3 days the cells were
isolated from the tendon explants using enzymatic digestion as
described above and the surviving cells were counted twice in a
Neubauer chamber using Trypan blue (Molecular Probes, Life
Technologies). Viable cell density was calculated by normalizing
the average number of living cells to the initial wet weight of the
explants.
2.8. Differential scanning calorimetry in explants
Explants from ﬁve animals were treated over the full range of
concentrations and incubation times. After brieﬂy blotting with pa-
per to remove excess moisture, they were wet weighed and placed
with the largest ﬂat area onto the bottom of stainless steel pans to
guarantee optimal heat transfer. After calibration of the differential
scanning calorimeter (2920 calorimeter, TA Instruments, Delaware
US), the pans were sealed and ramped at a constant heat rate of
10 C min1 from 0 to 120 C using an empty pan as the reference.
Denaturation was determined as the temperature at the peak heat
ﬂow in the endotherm (tm). As enthalpy has been previously shown
to be insensitive to exogenous collagen crosslinking, it was not
considered in the analysis [32]. Some pans were opened following
DSC measurements, and the samples were dried in an oven for 16 h
at 130 C to determine the dry weight, which was then considered
with the wet weight to determine water content [33].
2.9. Gene expression analysis
Cells fromeight animalswere cultured in a reduced range of con-
centrations (cGEN: 0, 0.1 and 1 mM) for 3 days at 37 C and 5% CO2. At
harvesting, cell cultureswere resuspended in RNA-Bee™ (TEL-TEST,
Friendswood, TX, USA). RNA was precipitated and reverse tran-
scribed into cDNA using RevertAid™ First Strand cDNA Synthesis
Kit (MBI Fermentas, St. Leon-Rot, Germany). As markers of matrix
metabolism, we assayed the genes for collagen type 1 and matrix
metalloproteinase 1, as well as the apoptotic marker caspase 3
(Table 1). As an internal control, the housekeeping gene glyceralde-
hyde 3-phosphate dehydrogenase was used after veriﬁcation that it
was stably expressed across sample conditions (data not shown).
Ampliﬁcations were performed in duplicates for the tested genes
and quadruple for internal controls using a Power Sybr green poly-
merase chain reaction (PCR) master mix (Molecular Probes, Life
Technologies) according to standard manufacturer guidelines.
Quantitative real-time PCR was performed (StepOnePlus™, Applied
Biosystems, Life Technologies, Paisley, UK) and analyzed using the
device software describedmethod. Averaged gene expressions rela-
tive to the housekeeping gene were calculated according to the
2DCT method and used to discriminate between groups [34].
2.10. Mechanical testing
Uniaxial tensile testing was performed with small modiﬁcations
to previously described protocols, where the power and effective-
ness of the employed experimental setup were reported
[9,35,36]. Due to the large quantities of tissue needed for mechan-
ical tests, tendons were collected and frozen until the day of test-
ing/treatment. At the start of the experiment, tendons were
thawed for 1 h at room temperature. During sample processing
Table 1
Horse speciﬁc primers: nucleotide sequences of the tested genes.
Gene Accession No. Product length (bp) Primers Sequences (50 ? 30)
Casp 3 (Caspase 3) NM_001163961 127 F: TCA-GGC-CTG-CCG-AGG-TAC-AGA
R: ACC-AGG-TGC-TGT-GGA-ATA-CGC-A
Col1A1 (collagen IA1) XM_001499586 164 F: TGC-CAT-CAA-AGT-CTT-CTG-CAA
R: CGC-CAT-ACT-CGA-ACT-GGA-ATC
MMP-1 (matrix metalloproteinase-1) NM_001081847 92 F: CGA-AGG-GAA-CCC-TCG-GTG-GGA
R: TGG-CCT-GGT-CCA-CAT-CTG-CTC
GAPDH (housekeeping gene) NM_001163856 141 F: GTC-AAC-GGA-TTT-GGT-CGT-ATT-GGG
R: TGC-CAT-GGG-TGG-AAT-CAT-ATT-GG
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and tensile testing, dehydration of the samples was avoided by
covering them with sterile gauze soaked in phosphate-buffered
saline (PBS), or by spraying them with PBS such that a liquid ﬁlm
was visible on the samples. All of the sample processing and tensile
testing was performed at room temperature. Single strips of ten-
don were subsectioned into either triplets or pairs (triplet = 13,
pairs = 11), each of approximately 1  3  50 mm3, using a hand-
held device with three microtome blades aligned in parallel (high
proﬁle, PTFE coated, 7310, DuraEdge) [9]. All samples were free
from the surrounding connective tissue (epitenon). Some resident
collagen ﬁbers were likely disrupted, leading to lower values of
stiffness and strength compared to whole tendon mechanical prop-
erties. Strips from each triplet/pair were then pseudo-randomly
allocated either to the control or to one of the GEN treatment
groups. The precise cross-sectional area of each specimen was
assessed by averaging triplicate readings from a CCD-based
custom linear laser scanner (accuracy: 3.52 ± 1.89%, precision:
0.83%; for details see supplementary materials S-1 and S-1 Fig. 1)
adapted from the system described by Vergari et al. [37]. On aver-
age, cross-sectional area was 3.9 ± 0.7mm2, with no differences be-
tween groups (analysis of variance (ANOVA), p = 0.952). Samples
were then mounted in custom clamps after being wrapped in
two saline soaked pieces of cloth to reduce slippage and clamping
damage [35]. Samples were preconditioned 10 times up to 6 MPa,
corresponding to the end of the heel region and the onset of the
linear region of the material curve. Upon preconditioning, the
stress–strain curves became congruent within 10 cycles, without
any apparent damage. After the 11th cycle to an applied stress of
6 MPa, the sample was held stretched and allowed to relax for
300 s (relaxation experiment). Relaxation was simply assessed as
the relative stress decay over time, and the end value was used
for statistical analysis. Displacement measurements were normal-
ized to nominal strain based on the initial length (L0) at a tare
stress corresponding to 0.05 MPa. After a recovery time again of
300 s, samples were ramped to failure at a constant strain rate of
0.5% L0 s1, the strain rate used in all tests (Fig. 1). The nominal
stress was calculated based on initial cross-sectional area before
treatment. The elastic mechanical properties were measured as
the tangential elastic modulus in the linear part of the stress–strain
curve. The region of the 20% highest values of the numerical gradi-
ent of the stress–strain curve was used to deﬁne the linear range.
First-order polynomials were ﬁtted to the linear range, with the
slope being the tangential elastic modulus. The linear ﬁt was then
shifted by 0.2% strain to determine the yield point as the intersec-
tion of the stress–strain curve with the linear ﬁt. Maximal stress
and corresponding strain (ultimate strength) and strain energy
densities up to the yield point were calculated numerically [33].
2.11. Statistical analysis
Normalized outcomes from cytotoxicity experiments (here:%
cell viability/metabolism/motility of 100% for controls) were ana-
lyzed using probit regression (factor: treatment time; covariate:
dose), since this model ﬁts the sigmoidal dose–response curves of
toxicity experiments well. A probit regression ﬁts dichotomous/
binominal dependent variables (e.g. cells being dead/alive) and is
commonly used in toxicology to estimate lethal doses (e.g. LD50).
The sigmoid dose–response data (dependent variable) is trans-
formed to become continuous, not limited by 0 and 1, and linear,
and can then be analyzed similarly to a linear regression. The probit
model was used to estimate toxicity (potency) together with 95%
conﬁdence intervals of the GEN treatment in terms of relative ef-
fects on cells (similar to LD50). In case there was a common slope
for the regression lines for all treatment times (v2-parallelism test,
p < 0.05), axes intercepts and relative potencies were used to assess
the effect of treatment duration on cells, after having assessed an
adequate model ﬁt (Pearson’s goodness-of-ﬁt v2-tests: p > 0.15).
The response of the DSC (tm) was assessed by analysis of covariance
(ANCOVA, ﬁxed factor: treatment time; covariate: concentration),
yielding regression lines for each treatment time. In case there
was no signiﬁcant difference of the interaction term (indicating dif-
ferences of the slopes of regression lines/covariate), the model was
additionally reduced to a one-way ANOVA to assess signiﬁcant ef-
fects of concentration (ﬁxed factor: concentration). Post hoc pair-
wise comparison was performed using Bonferroni correction. Cell
motility and mechanical properties were assessed by two-way
ANOVAs for randomized block designs (random factor: horse; ﬁxed
factor: treatment) and post hoc pairwise comparison was used to
discriminate between treatment group effects using Bonferroni cor-
rection or, in some cases, Dunnett’s test to compare test groups
against controls. In case the model assumptions (sphericity) were
not met, Greenhouse–Geisser adjustment or the multivariate anal-
ysis of variance (MANOVA) approach was used. Gene expression
was assessed by Friedman’s test, the non-parametric alternative
to the blocked ANOVA. In all statistical tests, differences were
deemed signiﬁcant with p 6 0.05 and were deemed trends with
p 6 0.1. In all cases, two-sided tests were performed. Results are re-
ported as means with standard deviations, if not stated otherwise.
All statistics were performed using SPSS v21.0 (IBM Corporation,
New York, NY) and/or Matlab R2013a (MathWorks, Natick, MA).
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Fig. 1. (Top) Schematic description of parameters used to analyze mechanical data.
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triple of tendon strips cut from the same tendon.
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3. Results
With increasing GEN concentration and time of incubation, the
color of the tendon explants changed from light to dark blue,
indicating a reaction of GEN with primary amines (Fig. 2, top).
Consistent with the dose- and time-dependent discoloration,
homogeneous crosslinking was indicated by uniform ﬂuorescence
throughout the cut sections (Fig. 2, bottom).
The probit model indicated that cell viability was clearly con-
centration dependent and that cell viability was reduced in the
144 h treatment group; in other words, the 144 h GEN treatment
was more potent/toxic. This can be seen by a signiﬁcant leftward
shift (toward lower concentrations) of the regression line and an
increased potency for the 144 h group (details can be seen in
Fig. 4, left, and Tables 2–4). While cell rounding was noted at inter-
mediate concentrations, the two highest tested GEN concentra-
tions (10 and 20 mM) apparently ﬁxed the (dead) cell
morphology in an elongated state, which is normal for tenocytes.
Fluorescence observed throughout the cells may have indicated
GEN crosslinking of cellular and intracellular proteins (Fig. 4).
Metabolic activity was also clearly affected in a concentration-
dependent manner, coupled with a non-signiﬁcant reduction of
metabolic activity in the 144 h treatment group. These effects
can be seen as a non-signiﬁcant leftward shift of the regression line
and a non-signiﬁcantly increased potency of GEN (Fig. 3, middle,
and Tables 2–4).
Cell viability in tendon explants was similarly concentration
dependent according to the probit model. However, cell survival
was not reduced in the 144 h treatment group, with no signiﬁ-
cantly shifted curves and no signiﬁcant reduction in treatment ef-
fect (Fig. 3, right, and Tables 2–4).
Two-way ANOVA showed a signiﬁcant effect of cGEN on migra-
tion speed, with no variation over time after scratch application
(Fig. 5 and Tables 3 and 4). Post hoc pairwise comparison indicated
signiﬁcantly reduced migration speeds in 1 mM and higher cGEN.
ANCOVA revealed a common slope of the regression model ﬁtted
to the denaturation temperature, which indicated insuffuciency
of treatment duration (interaction term, p = 0.16). Therefore, the
ANCOVA was reduced to a one-way ANOVA that was dependent
on dose only. This showed a signiﬁcant effect of concentration with
increasing denaturation temperature from 5 mM up (Fig. 6 and
Table 4).
Friedman’s test revealed a signiﬁcant effect of the GEN treat-
ment on collagen type 1 gene expression. An 83% reduction in
the relative gene expression (2DCT) was observed in the 1 mM
GEN group compared to the 0 mM GEN controls, as was a trend
of 23% decreased relative expression in the 0.1 mM GEN group
(Fig. 7 and Table 4). The cell apoptosis marker caspase 3 and
MMP 1 both remained unaffected over the tested range of
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according to alamarBlue assay. The probit model (goodness of ﬁt: p = 1; common slope: p = 0.907) indicated signiﬁcant effects of dose (dose: p < 0.0001). There was no
signiﬁcant difference with time (axes intercept: p > 0.05). (Right) Normalized cell viability of explants from different horses as assessed by Trypan blue. The probit model
(goodness of ﬁt: p = 1; common slope: p = 0.477) indicated signiﬁcant effects of dose (dose: p = 0.03). There was no signiﬁcant difference with time (axes intercept: p > 0.05).
Here, each data point is a measurement from a sample (averaged over duplicate measurements (nm = 2) and this variability is not plotted). Note that, since log10(0 mM) is not
deﬁned, this data point was plotted at twice the distance between the two lowest non-zero concentrations on the log10 scale, therefore at 0.003 mM. Lines represent the
probit models. 24 h GEN treatment, 72 h GEN treatment, 144 h GEN treatment.
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concentrations (Fig. 7 and Table 4). During tensile mechanical test-
ing, one triplet failed during mechanical preconditioning and was
therefore excluded from further analysis. Tangent elastic modulus
increased signiﬁcantly, by 34%, after 20 mM GEN treatment, as as-
sessed by the paired (Student’s) t-test (Fig. 8 and Tables 4 and 5).
MANOVA for blocked design (ANOVA for complete randomized
block design was replaced due to violation of model assumptions)
also showed a signiﬁcant treatment effect on the elastic modulus.
A signiﬁcant 23% increase was observed in the 5 mM treatment
group. A non-signiﬁcant 14% increased elastic modulus was ob-
served in the 1 mM group compared to controls using post hoc
pairwise comparison. Relaxation, measured as relative stress decay
over 300 s, was not signiﬁcantly reduced due to crosslinking
(0 mM: 10.3 ± 1.1%, 1 mM: 10.2 ± 1.6% and 5 mM: 9.5 ± 1.0%,
p = 0.231). This measure of viscoelasticity was nevertheless larger
in controls, and became smaller with increasing concentration.
All further parameters assessed by two-way ANOVAs for the con-
centrations 1 and 5 mM, as well according to t-test on the
20 mM group, remained unaffected (Tables 4 and 5). Finally, treat-
ments had no statistical effect on tissue swelling (6.0 ± 6.7%,
p = 0.948) from an initial water content of 75.2 ± 4.8%. Also, initial
lengths were very similar between groups (23.7 ± 1.2 mm,
p = 0.796).
4. Discussion
Crosslinking of collagen-based implants has been widely used
to augment their strength, elasticity, and resistance to fatigue-
induced mechanical damage and premature degradation by the
host system [5]. Crosslinking can improve implant survival within
challenging mechanical environments, such as the cardiovascular
and musculoskeletal systems. Genipin (GEN) is a plant-derived col-
lagen crosslinking agent that has been demonstrated to be highly
mechanically effective yet substantially less cytotoxic than tradi-
tional chemical crosslinking agents like glutaraldehyde. Given the
efﬁcacy and relatively low cytotoxicity of GEN, it has emerged as
a candidate for in vivo application, with various studies demon-
strating proof of principle for in situ biomechanical efﬁcacy in
treating keratoconus of the eye [38] and ruptures of the interverte-
bral disc annulus [8,39]. Our own work has shown it to be capable
of arresting damage propagation in an in vitro model of tendon
tear, being able to restore normal levels of tissue strains [5].
While GEN seems to offer promise as an in vivo collagen
crosslinking agent, it has been reported to be cytotoxic at moderate
concentrations, which vary depending on cell type (typically 0.5–
5 mM). Until now it has been unclear whether a dense collagen
matrix of connective tissues, like that in tendon, could be biome-
chanically augmented in situ without adverse consequences for
the resident cell populations. The present study sought to deﬁne
ranges of cytotoxicity for tendon cells, and then determine
whether functionally relevant changes in tissue mechanics could
be attained at these concentrations and exposure times. The over-
all goal was to better delineate the range of potential in situ appli-
cations that GEN may have, and provide dosing guidance for the
development of delivery strategies.
0.05  mM0.08 mM0.1 mM0.2 mM
300 µm
20 mM 10 mM 5 mM 2.5 mM 1 mM 0.8 mM 0.5 mM
0.02  mM + Control - Control
Fig. 4. Cell viability tested by live/dead assay. Red-stained cell nuclei indicate cell death. Green staining indicates vital cells. The present images were taken after 72 h of GEN
treatment. Magniﬁcation:10; C+: positive (sham) control; C: negative control (ethanol-treated cells). Visible cell death is apparent at GEN concentrations starting at
2.5 mM, increasing in a dose-dependent manner. An elongated morphology is phenotypic of healthy tenocytes.
Table 2
Relative potency/toxicity (the ratio of the slope from the regression models) was used
to estimate the effect of treatment time on cells.
Test Comparison Relative potency LCI UCI
Live/dead 24 h vs.72 h 0.73 0.22 2.24
24 h vs. 144 h 2.35 0.78 7.74
72 h vs. 144 h 3.23 1.01 12.13
alamarBlue 24 h vs.72 h 0.96 0.44 2.11
24 h vs. 144 h 1.67 0.78 3.92
72 h vs. 144 h 1.74 0.79 4.18
Trypan blue 72 h vs. 144 h 0.60 0.00 20.95
A signiﬁcant effect is marked by a relative potency (between two treatment times)
that is different than one (the number 1 indicates no change). This is true, if the
upper 95% conﬁdence interval (UCI) and lower 95% conﬁdence interval (LCI) do not
include one. Signiﬁcant difference is noted bold.
Table 3
Selected potencies/toxicities of GEN treatment at 72 h: a probit regression model was used to estimate at which concentrations a change in tendon cell viability, metabolic
activity or motility occurred (the relative effect).
Relative effect
(% of control)
Cell culture viability (Live/dead) Metabolic activity (alamarBlue) Explants viability (Trypan blue) Cell motility (scratch wound)
Estimated cGEN LCI UCI Estimated cGEN LCI UCI Estimated cGEN LCI UCI Estimated cGEN LCI UCI
(mM) (mM) (mM) (mM) (mM) (mM) (mM) (mM) (mM) (mM) (mM) (mM)
90 0.12 0.04 0.31 0.03 0.01 0.06 0.01 7.8E10 0.51 0.62 0 18.47
80 0.5 0.2 1.1 0.07 0.03 0.1 0.03 1.2E05 40.8 0.74 0 766
70 1.2 0.5 2.9 0.13 0.07 0.2 0.1 0.001 18307.8 0.9 0.002 1.0E+08
60 2.8 1.2 7.1 0.2 0.13 0.4 0.2 0.004 1.6E+07 1.1 0.05 3.1E+16
50 6.2 2.7 16.9 0.4 0.2 0.7 0.3 0.01 1.6E+10 1.3 0.17 2.2E+26
40 13.3 5.5 41.7 0.6 0.4 1.2 0.6 0.03 2.3E+13 1.6 0.31 1.8E+37
30 30.4 11.6 112.7 1.1 0.6 2.1 1.2 0.1 6.3E+16 2.0 0.5 3.3E+49
20 79.7 27.2 370.4 2.1 1.1 4.4 2.9 0.1 7.5E+20 2.6 0.7 7.5E+63
10 303.9 85.9 1986.9 5.1 2.6 12.4 9.3 0.3 3.8E+26 3.6 1.0 9.8E+81
The relative effects refer to sham-treated controls (0 mM GEN) as 100%: for example, at 6.2 mMGEN (cGEN) 50% of cells survive compared to untreated controls. LCI: lower 95%
conﬁdence interval; UCI: upper 95% conﬁdence intervals.
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To provide a basis for effective in vivo dosing, we used probit
regression to ﬁt our experimental data. For instance, the model
predicts that approximately 50% of cells would remain viable at
GEN concentrations of 6.2 mM applied for 72 h (Table 3), with
decreasing cell viability after more prolonged incubation (Fig. 3
and Table 2). While many cells remain alive at concentrations of
5 mM or less for the time spans we studied, effects on cell metab-
olism occurred at substantially lower concentrations. The probit
model predicts a 50% drop in metabolic activity at a concentration
of 0.4 mM after 72 h, with a trend to additional decreases in cell
metabolism after 144 h of treatment (Fig. 3 and Tables 2 and 3).
These ﬁndings were consistent with reduced cell motility at similar
concentrations (Fig. 5 and Table 3). While reduced collagen I
expression was also consistent with reduced metabolic activity,
apoptosis markers and matrix degradation markers were not af-
fected – a favorable ﬁnding regarding potential of GEN for in vivo
application. Functional, physical effects on the matrix were statis-
tically signiﬁcant only at the tested concentration above 5 mM, and
were independent of time of incubation (Figs. 6 and 8 and Table 5).
We attribute these effects to homogeneous crosslink formation
throughout the explants seen by ﬂuorescence (Fig. 2). Interestingly,
GEN crosslinking of cartilage scaffolds has an increasing effect on
mechanical properties with longer treatment [16], and that effect
can start from 2 h on, as measured in collagen gels [30]; similarly,
GEN crosslinking increases the mechanical properties of rat tail
tendon within 4.5 h [9]. Therefore, it is not clear whether our lack
of time dependence is a result of underpowered experiments, low
sensitivity of the tests or actual independence from the time of
incubation.
Although a main aim of the work was to identify ‘‘cell-safe’’ and
‘‘matrix-effective’’ GEN dosing guidelines, it is clear that these
objectives may be mutually exclusive to some extent. It appears
that 5 mM (and maybe slightly lower concentrations) are able to
induce relatively rapid crosslinking while leaving subpopulations
of resident cells viable. Toward clinical application of in situ cross-
linking to arrest tendon tear propagation, we believe a dosage of
5 mM or slightly lower with a dosing duration of 72 h would be
a reasonable starting point for in vivo study. Although the degree
of cytotoxicity that can be tolerated in vivo will vary according
to the targeted tissue and clinical indication, properly balancing
the need for rapid improvement in tissue function against the
long-term consequence of altered cell and matrix metabolism will
be imperative. No less important will be the need to develop effec-
tive vehicles for targeted crosslink delivery. Delivery of exogenous
crosslinks that augment tissues at the intended site without ad-
versely affecting neighboring tissues (e.g. tendon sheaths) represents
a major challenge and is a thrust of ongoing work in our laboratory.
While robust augmentation of elasticity at 5 and 20 mM GEN
concentrations is in line with our previous work at 20 mM [9],
the mechanical effects in the present study were less drastic. This
can be partly attributed to the slightly reduced sample number
used here. Even considering the effects of sham incubation, which
yielded trends of increased elastic modulus, ultimate strength and
corresponding strain by 10–15% over the native tissue (data not
shown), we remain conﬁdent of GEN augmentation effects in the
present treatments.
When comparing the current studies to other investigations of
GEN on tissues and cells, the present observed lack of time-
dependent effects on cytotoxicity for culture periods of up to
72 h echoes previous studies on osteoblastic cells [24]. This study
reported no observable cytotoxic effects in 0.044 mM GEN solu-
tion, while 0.44 mM GEN induced a 50% reduction in metabolic
activity of ﬁbroblasts [25]. These ﬁndings are in close agreement
with our model prediction of 50% reduction in cell metabolism at
0.38 mM (95% conﬁdence intervals: 0.22 and 0.69 mM). These re-
sults somewhat contradict other reports of limited cytotoxic ef-
fects on chondrocytes within explants treated up to 42 days at
concentrations of 0.22 mM, and this while attaining mechanical
enhancement of the tissue [16]. They also stand in contrast with
another study reporting little cytotoxicity after crosslinking por-
cine heart valves in 8 mM GEN while obtaining a near doubling
of stiffness [27].
While the current study was intended to be fairly comprehen-
sive, several limitations must be noted. First, focused investigation
Table 4
Summary of statistical tests of the main experimental outcomes along with p-values.
Measures Statistical tests Repeated measure/block cGEN
Cell motility
Migration speed Two-way ANOVA 0.371 <0.0001
DSC
Denaturation temperature One-way ANOVA – <0.0001
Gene expression
Casp 3 (2-DCT) Friedman’s test – 0.882
Col A1 (2-DCT) Friedman’s test – 0.01
MMP 1 (2-DCT) Friedman’s test – 0.607
Mechanical test
Relaxation Two-way ANOVA 0.01 0.231
Elastic modulus Two-way MANOVA <0.0001 0.011
t-test – 0.014
Yield stress Two-way ANOVA <0.0001 0.395
t-test – 0.227
Yield strain Two-way ANOVA <0.0001 0.384
t-test – 0.156
Ultimate strength Two-way ANOVA <0.0001 0.387
t-test – 0.187
Strain at ult. strength Two-way ANOVA 0.01 0.906
t-test – 0.397
Energy up to yield Two-way ANOVA 0.01 0.638
t-test – 0.444
Statistical signiﬁcance (p < 0.05) is noted by bold text. Measures: indicated are the tests used and the parameters that were analyzed. Statistical tests: Indicated are the tests
used to assess the measures. Parametric tests were used when the model assumptions were met. Otherwise, as indicated, an appropriate non-parametric alternative was
used. Repeated measure/block: p-values for all experiments are given. Some experiments were repeated multiple times and therefore the tissue/cells came from different
horses. In the analysis a corresponding blocking factor was added to the ANOVAs. cGen: p-values given for the factor GEN concentration (from 0 to 20 mM). For the mechanical
tests the 20 mM group was separately assessed with own-paired controls.
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in narrower windows was deemed to be beyond the scope of this
study. Such investigations will be necessary according to the clin-
ical indication and the eventual GEN delivery approach that is
utilized – aspects that were not explicitly addressed in the current
study. Further, whether the effects we observed prove generally
applicable to other dense connective tissues and clinical applica-
tions remains to be investigated. Nonetheless, the current study
provides a useful baseline for dosage guidance in the design of
future in vivo studies, and will be helpful in interpreting their
outcome. As a further limitation, we observed slight increases in
pH (maximally: 0.2) that were attributable to the addition of low
GEN concentrations up to 2.5 mM. Since GEN crosslinking,
self-polymerization before crosslinking and the crosslink effects
on the physical properties of biopolymers have all been shown to
be pH dependent [11,12], we cannot exclude confounding effects
of these pH differences. However, the scales used to assess the
effects of pH in those studies were at least tenfold the differences
described here. Also, such small differences have only a marginal
effect on cell viability and metabolism.
Finally, we note that the occasionally large variability within
the various performed experiments can be attributed to similarly
large variability across animals, and across specimens from a single
donor tissue. Inter-specimen variability can be attributed to
handling factors like anatomical sampling location, difﬁculties
when cutting the strips along the main collagen direction and chal-
lenges in assessing the wet weight of small samples (hydration and
dehydration effects). A further limitation is that the present study
focused only on acute and relatively rapid crosslinking effects,
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Fig. 5. Left axes: cell migration speed (lm h1) was averaged over time of image
acquisition after scratch application (nm = 3) and over experiments in different
animals (nr = 3). Horizontal bars indicate signiﬁcant differences. Only signiﬁcant
differences between adjacent groups were plotted, as all other pairwise compar-
isons were signiﬁcantly different. Right axes: probit ﬁt of normalized cell migration
speeds. 0 mM GEN is plotted at 0.003 mM. 72 h GEN treatment.
68
72
76
80
84
C
on
t.
0.
02
0.
05
0 .
08 0.
1
0 .
2
0 .
5
0.
8 1
2.
5 5 10 20
68
72
76
80
84
0.00 0.01 0.10 1.00 10.00
D
en
at
ur
at
io
n 
T
 [°
C
]
m
C [mM]GEN
D
en
at
ur
at
io
n 
T
 [°
C
]
m
C [mM]GEN
p=0.002
p<0.0001
p<0.0001 p<0.0001
p=0.003
p=0.028
Fig. 6. (Left) denaturation temperatures as measured by DSC. Fit: linear model (tm = 0.66 C/mM  [GEN] mM + 69.26 C, R2 = 0.96) with log10 transformed concentrations
and 95% conﬁdence intervals. 0 mM GEN is plotted at 0.003 mM. 24 h GEN treatment, 72 h GEN treatment, 144 h GEN treatment. (Right) Bars indicate signiﬁcant
differences from post hoc pairwise comparison with a signiﬁcant main effect. Only signiﬁcant differences between adjacent groups or to controls were plotted as all other
pairwise comparisons were signiﬁcantly different, except below a concentration of 2.5 mM, for which there was no effect. Markers of the same color but different shape ( ,
and ) indicate samples from the same experimental condition but from different horses.
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Fig. 7. Relative gene expression (2DCT) normalized to an internal standard (housekeeping gene: GADHP): the non-parametric counterpart (Friedman’s test) of a two-way
blocked ANOVA was run with appropriated post hoc pairwise comparison since ANOVA assumptions were not met. A 5 mM GEN group was also tested; however, due to the
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Fig. 8. Relative changes of elastic modulus compared to sham-treated controls
(dashed line). The 20 mM group was separately assessed with its own matched
controls, since the use of samples dissected into quadruplicates resulted in overly
large inter-quadruple variability. This would have precluded the blocked experi-
mental setup necessary to identify effects of crosslinking.
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neither investigating whether long-term administration of GEN at
lower doses (1 mM or less) could possibly achieve a cumulative
functional effect with less pronounced cytotoxicity nor observing
the continuity of the documented effects. Finally, on a more basic
level, we did not investigate how GEN crosslinks are actually
formed or remain stabilized within tissue – factors that may vary
depending upon the dosing concentration and time. While this
information may be helpful to interpreting our results, we note
that others have reported that the stabilizing effects of GEN are
comparable to glutaraldehyde [40].
5. Conclusions
The crosslinking agent genipin is increasingly invoked for the
mechanical augmentation of collagen tissues and implants, and
has been demonstrated to arrest mechanically driven tissue degen-
eration. This study established an in vitro dose–response baseline
for the effects of genipin treatment on tendon cells and their ma-
trix, with a view to in vivo application for the repair of partial ten-
don tears. Regression models based on a broad range of
experimental data were used to delineate the range of concentra-
tions that are likely to achieve functionally effective crosslinking,
and to predict the corresponding degree of cell loss and diminished
metabolic activity that can be expected. The data indicate that ra-
pid mechanical augmentation of tissue properties can only be
achieved by accepting some degree of cytotoxicity, but that post-
treatment cell survival may be adequate to eventually repopulate
and stabilize the tissue. On this basis, it can be concluded that
development of delivery strategies and subsequent in vivo study
is warranted.
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